Compound Profile

Cryptotanshinone

Abietane diterpenoid from Salvia miltiorrhiza (Danshen) root with JAK2/STAT3 inhibitory and anti inflammatory properties.

Last reviewed: 1 human studies cited

C Preliminary

Monograph visual

Cryptotanshinone

Generated profile category visual

Where to go next — guides & comparisons

Continue reading

Quick Stats

Evidence level

Limited evidence

Typical onset

Varies by prep

Safety rating

Use extra caution: Use caution

Best for

NF κB, MAPK, Platelet Aggregation

Found In

Botanicals that contain Cryptotanshinone, with full herb profiles.

Safety & Cautions

Danshen constituents may affect bleeding and cardiovascular medications; use clinician review with anticoagulants/antiplatelets.

Evidence-based safety

Caution when combined

These pairings share a flagged risk mechanism. They are additive-effect cautions derived from contraindication data, not confirmed clinical interactions. Consult a clinician before combining.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Browse the grouped cautions below. The list scrolls inside this card when long.

Bleeding / anticoagulant risk

Evidence Summary

C Preliminary

Evidence lens

Early signal that needs stronger human replication before practical claims.

PreliminaryLimited evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedInflammatory Signaling Modulation · Vascular Function Support · NF KB Modulation

Research maturity: Preliminary or mixedmain contexts: NF κB · MAPK · Platelet Aggregation

Safety boundary: Safety note availableDanshen constituents may affect bleeding and cardiovascular medications; use clinician review with anticoagulants/antiplatelets.

This profile cites 1 human study.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Limited evidence

Cryptotanshinone has a limited evidence evidence rating.

General wellnessGeneral wellness
Citation density
0.3
Sources
1
Effects
4
Research recency
Mixed recency
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

A

Strong

Multiple RCTs, consistent direction, adequate effect size

B

Moderate

Some RCTs or consistent observational data in humans

C

Preliminary / Mixed

Animal or in-vitro only, or conflicting human data

D

Traditional / Theoretical

Traditional use only; no controlled human trials

Clinical Study Summaries (1)Cited studies informing this profile. RCTs and reviews shown first.

How Cryptotanshinone Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Cryptotanshinone Works

How Cryptotanshinone WorksCryptotanshinone acts on pathways via anti inflammatory, leading to nf κb.CryptotanshinoneBiological pathwayAnti InflammatoryNf κBObservable outcomeVascular FunctionSupport
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

Inflammatory Signaling ModulationVascular Function SupportNF KB ModulationInflammatory

Condition guides

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Cryptotanshinone

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Free safety checklist

Get the Cryptotanshinone evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Compound profile context

How to interpret Cryptotanshinone

Cryptotanshinone dosage by use case, onset and duration, safety limits, and interactions for nf κb, graded against research. Limited Human Evidence research… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing Cryptotanshinone, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.